Tamoxifen lowers breast cancer rates in women at high risk
Tamoxifen acts as a preventive drug in women with a family history of breast cancer. Users of tamoxifen have a 30 percent lower risk, compared to women who do not use the drug. That is the conclusion of new research conducted at the British Queen Mary University, London. The results have been published in The Lancet Oncology. Continue reading